Physician profile
Sheldon D Roberts
NPI 1497795504
$4,218.82
in general payments reported to CMS, 2019-2025
39 companies · $735 in 2025
The $735 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $401 · 2021: $809 · 2022: $727 · 2023: $401 · 2024: $592 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,728.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $965.22 | 2019-2025 | Xtandi |
| Pfizer INC. | $428.00 | 2019-2025 | |
| Coloplast Corp | $408.72 | 2019-2024 | Porges Coloplast |
| Boston Scientific Corporation | $264.23 | 2019-2025 | Spaceoar Vue System - 10ml, Axonics |
| Abbvie INC. | $261.99 | 2019-2025 | Botox |
| Janssen Biotech, INC. | $198.51 | 2019-2024 | Erleada |
| Sumitomo Pharma America, INC. | $166.61 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $136.13 | 2024-2025 | Adstiladrin |
| Allergan, INC. | $129.80 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $93.43 | 2019-2022 | |
| Urogen Pharma, INC. | $88.92 | 2021-2024 | |
| Agiliti Surgical, INC. | $81.85 | 2022 | |
| Axonics, INC. | $77.54 | 2020-2023 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $73.21 | 2019-2021 | |
| Calyxo, INC. | $71.52 | 2025 | Cvac Aspiration System |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.